Stimulant dependence and stimulant-associated psychosis: Clinical characteristics and age of onset in a native American community sample david

Journal of Addiction Medicine

Volumn 8, Issue 4, 2014, Pages 241-248

  Gilder, David A ^a   Gizer, Ian R ^b   Lau, Philip ^a   Ehlers, Cindy L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Native Americans; Psychosis; Risk factors; Stimulant dependence

Indexed keywords

ADOLESCENT; ADULT; AGED; AMERICAN INDIAN; AMPHETAMINE-RELATED DISORDERS; COCAINE-RELATED DISORDERS; COMPLICATION; FEMALE; HUMAN; MALE; MENTAL DISORDERS; MIDDLE AGED; ONSET AGE; PROTECTION; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; PSYCHOSES, SUBSTANCE-INDUCED; REMISSION; RISK FACTOR; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMPHETAMINE-RELATED DISORDERS; COCAINE-RELATED DISORDERS; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MENTAL DISORDERS; MIDDLE AGED; PROTECTIVE FACTORS; PSYCHOSES, SUBSTANCE-INDUCED; REMISSION INDUCTION; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84905866622     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000039     Document Type: Article

References (40)

1. Brady KT, Lydiard RB, Malcolm R, et al. Cocaine-induced psychosis. J Clin Psychiatry 1991;52:509-512.
2. Bramness JG, Gundersen OH, Guterstam J, et al. Amphetamine-induced psychosis-a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry 2012;12:221.
3. Bucholz KK, Cadoret R, Cloninger CR, et al. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994;55:149-158.
4. Calabria B, Degenhardt L, Briegleb C, et al. Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence. Addict Behav 2010;35:741-749.
5. Chen CK, Lin SK, Sham PC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 2003;33:1407-1414.
6. Compton WM, Conway KP, Stinson FS, et al. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2005;66:677-685.
7. Conway KP, Compton W, Stinson FS, et al. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:247-257.
8. Dickerson DL, Fisher DG, Reynolds GL, et al. Substance use patterns among high-risk American Indians/Alaska Natives in Los Angeles County. Am J Addict 2012;21:445-452.
9. Ehlers CL, Wall TL, Betancourt M, et al. The clinical course of alcoholism in 243 Mission Indians. Am J Psychiatry 2004;161:1204-1210.
10. Ehlers CL, Gilder DA, Phillips E. P3 components of the event-related potential and marijuana dependence in Southwest California Indians. Addict Biol 2008;13:130-142.
11. Evans E, Spear SE, Huang YC, et al. Outcomes of drug and alcohol treatment programs among American Indians in California. Am J Public Health 2006;96:889-896.
12. Forcehimes AA, Venner KL, Bogenschutz MP, et al. American Indian methamphetamine and other drug use in the Southwestern United States. Cultur Divers Ethnic Minor Psychol 2011;17:366-376.
13. Gilder DA, Lau P, Corey L, et al. Factors associated with remission from cannabis dependence in southwest California Indians. J Addict Dis 2007;26:23-30.
14. Gilder DA, Lau P, Corey L, et al. Factors associated with remission from alcohol dependence in an American Indian community group. Am J Psychiatry 2008;165:1172-1178.
15. Grant KM, LeVan TD, Wells SM, et al. Methamphetamine-associated psychosis. J Neuroimmune Pharmacol 2012;7:113-139.
16. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl 1997;44:174-199.
17. Hesselbrock M, Easton C, Bucholz KK, et al. A validity study of the SSAGA- a comparison with the SCAN. Addiction 1999;94:1361-1370.
18. Hesselbrock MN, Hesselbrock VM, Segal B, et al. Ethnicity and psychiatric comorbidity among alcohol-dependent persons who receive inpatient treatment: African Americans, Alaska Natives, Caucasians, and Hispanics. Alcohol Clin Exp Res 2003;27:1368-1373.
19. Hesselbrock VM, Segal B, Hesselbrock MN. Alcohol dependence among Alaska Natives entering alcoholism treatment: a gender comparison. J Stud Alcohol 2000;61:150-156.
20. Indian Health Service. Resources and Patient Management System. Rockville, MD: US. Department of Health and Human Services, 2005. Available at: http://www.ihs.gov/RPMS/index.cfm?module=home&option= otherdocuments. Accessed March 25, 2014.
21. Indian Health Service. Trends in Indian Health 2002-2003 Edition. Rockville, MD: US Department of Health and Human Services, 2009. Available at: http://www.ihs.gov/dps/files/Trends 02-03 Brochure.pdf. Accessed February 19, 2014.
22. Iwanami A, Sugiyama A, Kuroki N, et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand 1994;89:428-432.
23. Johnston LD, O'Malley PM, Bachman JG. Monitoring the Future National Survey Results on Drug Use, 1975-2002: Volume II, College Students and Adults 19-40. Ann Arbor, MI: Institute for Social Research, The University of Michigan, 2011. NIH Publication No. 03-5376. Supported by NIDA. Available at: http://www.monitoringthefuture.org/pubs/monographs/mtf-vol2 2010.pdf. Accessed March 25, 2014.
24. Kalton G, Anderson DW. Sampling rare populations. J Roy Stat Soc 1986;149:65-82.
25. Lev-Ran S, Imtiaz S, Rehm J, et al. Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). Am J Addict 2013a;22:93-98.
26. Lev-Ran S, Le SY, Imtiaz S, et al. Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample. Am J Addict 2013b;22:7-13.
27. Lopez-Quintero C, Hasin DS, de Los Cobos JP, et al. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction 2011a;106:657-669.
28. Lopez-Quintero C, Perez de Los CJ, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2011b;115: 120-130.
29. McKetin R, McLaren J, Lubman DI, et al. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006;101:1473-1478.
30. Muhib FB, Lin LS, Stueve A, et al. A venue-based method for sampling hard-to-reach populations. Public Health Rep 2001;116(suppl 1):216-222.
31. Roncero C, Ros-Cucurull E, Daigre C, et al. Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients. Actas Esp Psiquiatr 2012;40:187-197.
32. Salo R, Flower K, Kielstein A, et al. Psychiatric comorbidity in metham-phetamine dependence. Psychiatry Res 2011;186:356-361.
33. Salo R, Nordahl TE, Leamon MH, et al. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Res 2008;157:273-277.
34. Smith MJ, Thirthalli J, Abdallah AB, et al. Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry 2009;50:245-250.
35. Substance Abuse and Mental Health Services Administration. DASIS Report: Substance Abuse Treatment Admissions Among American Indians and Alaska Natives: 2002. Rockville, MD: Office of Applied Studies, US Department of Health and Human Services, 2005a. Available at: http://www.drugabusestatistics.samhsa.gov/ 2k5/IndianTX/IndianTX.pdf. Accessed February 19, 2014.
36. Substance Abuse and Mental Health Services Administration. The NSDUH Report: Methamphetamine Use, Abuse and Dependence: 2002, 2003, and 2004. Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services, 2005b. Available at: http://oas.samhsa.gov/2k5/meth/meth.pdf. Accessed February 19, 2014.
37. Substance Abuse and Mental Health Services Administration. Results From the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, US Department of Health and Human Services, 2007. NSDUH Series H-32, DHHS Publication No. SMA-07-4293. Available at:http://www.samhsa.gov/data/nsduh/2k6nsduh/2k6results.pdf. Accessed February 19, 2014.
38. Substance Abuse and Mental Health Services Administration. Substance Use Among American Indian or Alaska Native Adolescents. Rockville, MD: Office of Applied Studies, US Department of Health and Human Services, 2011. Available at: http://www.samhsa.gov/data/2k11/WEB SR 005/SubsUse Among AmInd NatAlsk Adlscnt.pdf. Accessed February 19, 2014.
39. US Census Bureau. 2000 and 2010 censuses and the 2005-2009 and 2008-2012 American Community Survey 5-year estimates. Available at: http://www.census.gov/ . Accessed February 19, 2014.
40. Wu LT, Schlenger WE. Psychostimulant dependence in a community sample. Subst Use Misuse 2003;38:221-248.